Johnson & Johnson CEO Alex Gorsky, Baxter VP Brien Johnson to Keynote Summit

ATLANTA--(BUSINESS WIRE)-- The 11th annual Georgia’s Life Sciences Summit, Oct. 3, 2012, will feature Johnson & Johnson CEO Alex Gorsky and Baxter Healthcare’s Brien Johnson, Vice President, Program Manager, Plasma Bioscience.

Mr. Gorsky, who became Johnson & Johnson CEO in April, will be the luncheon keynote speaker focusing on the topic, “Future Forward: New Directions in Meeting Global Health Needs.” Mr. Johnson, who is overseeing the development of Baxter’s $1 billion biomanufacturing plant in Social Circle, will be the morning keynote speaker.

In addition, the Summit will feature more than 70 experts in 12 panel sessions discussing the latest trends and issues in the bioscience industry across Georgia, the nation and the world. The complete program with speaker bios is on the Summit website.

Also, the Summit will mark the release of the 2012 Georgia life sciences industry analysis, Shaping Infinity, produced by the University of Georgia’s Selig Center for Economic Growth. Read the report online here. Copies of the report, which details the economic significance of Georgia’s life sciences industry and features articles by industry and government leaders, will be available at the Summit.

Shaping Infinity, the sixth in a series, shows that one out of every 40 jobs in Georgia is tied to the life sciences industry. During the Great Recession, employment was stable, helping to offset the decline in jobs across all other industry sectors. The life sciences industry and university research, plus the U.S. Centers for Disease Control and Prevention, have a $20 billion annual economic impact on Georgia and employ more than 94,000 people. The industry’s impact alone is nearly $17 billion, employing more than 65,000 people in high-paying, rewarding careers.

From 2007 to 2010, employment in Georgia’s life sciences industry actually increased slightly, a remarkable achievement considering that total statewide employment for all industries declined by 8 percent. Georgia’s life sciences industry pays nearly $5.6 billion in salaries and more than $550 million a year in state and local taxes.

Registration is complimentary for credentialed members of the news media. To request media registration, please contact the Event Secretariat, 770-573-3020 /

Georgia Bio ( is the private, non-profit association representing the life sciences industry. Members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of products that improve the health and well-being of people, animals and the environment.

Georgia Bio
Charles Craig, 404-245-0591

Source: Georgia Bio